Nam H, Kim DY, Kim DY, Kim JH, et al. Development and validation of a risk prediction model for patients with hepatocellular carcinoma receiving atezolizumab-bevacizumab. Hepatology 2025 Jun 30. doi: 10.1097/HEP.0000000000001444.
PMID: 40587822